Literature DB >> 26492859

High-level aminoglycoside resistance in Enterococcus faecalis and Enterococcus faecium causing invasive infection: Twelve-year surveillance in the Minami Ibaraki Area.

Hanako Osuka1, Jun Nakajima2, Tsuyoshi Oishi1, Yasunori Funayama3, Tsugio Ebihara4, Hiroichi Ishikawa5, Kazuto Saito6, Hiroshi Koganemaru7, Shigemi Hitomi8.   

Abstract

We examined prevalence of high-level aminoglycoside resistance (HLAR) in Enterococcus faecalis and Enterococcus faecium causing invasive infection in the Minami Ibaraki Area. Ten strains of both species each, recovered from the blood or the cerebrospinal fluid between 2003 and 2014, were randomly selected every year. High-level resistance to gentamicin (HLR-GM) and streptomycin (HLR-SM) was detected in 34% (41 of 120 strains) and 18% (21) of E. faecalis and 9% (11) and 39% (48) of E. faecium, respectively. In comparisons of the proportions among three four-year periods, HLR-SM among E. faecium was significantly lower in the 2011-2014 period. All strains with HLR-GM were positive for the aac(6')-Ie-aph(2″)-Ia gene. The ant(6')-Ia gene was detected in all with HLR-SM except for one E. faecalis strain. The present study showed that prevalence of HLR-GM among E. faecalis and E. faecium causing invasive infection in this area was nearly equivalent to that described in previous studies in Japan and that proportions of strains with HLAR did not vary during the study period except for that of HLR-SM among E. faecium.
Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aminoglycoside-modifying enzyme; Enterococcus faecalis; Enterococcus faecium; Gentamicin; High-level aminoglycoside resistance; Streptomycin

Mesh:

Substances:

Year:  2015        PMID: 26492859     DOI: 10.1016/j.jiac.2015.09.003

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  6 in total

1.  High-level resistance to aminoglycosides and ampicillin among clinical isolates of Enterococcus species in an Iranian referral hospital.

Authors:  Seyed Hossein Mousavi; Hadi Peeri-Doghaheh; Behnam Mohammadi-Ghalehbin; Roghayeh Teimourpour; Dadras Maleki; Farzad Khademi; Mohsen Arzanlou
Journal:  Iran J Microbiol       Date:  2020-08

2.  High level aminoglycoside resistant enterococci in hospital-acquired urinary tract infections in Mansoura, Egypt.

Authors:  Rasha El-Mahdy; Ahmed Mostafa; Ghada El-Kannishy
Journal:  Germs       Date:  2018-12-03

3.  Identification of Emerging Human Mastitis Pathogens by MALDI-TOF and Assessment of Their Antibiotic Resistance Patterns.

Authors:  María Marín; Rebeca Arroyo; Irene Espinosa-Martos; Leónides Fernández; Juan M Rodríguez
Journal:  Front Microbiol       Date:  2017-07-12       Impact factor: 5.640

4.  Emergence of High-level Gentamicin Resistance among Enterococci Clinical Isolates from Burn Patients in South-west of Iran: Vancomycin Still Working.

Authors:  Maryam Labibzadeh; Gholam Abbas Kaydani; Mohammad Savari; Alireza Ekrami
Journal:  Pol J Microbiol       Date:  2018

5.  Aminoglycoside susceptibility of Pasteurella multocida isolates from bovine respiratory infections in China and mutations in ribosomal protein S5 associated with high-level induced spectinomycin resistance.

Authors:  Zi Wang; Ling-Cong Kong; Bo-Yan Jia; Shu-Ming Liu; Xiu-Yun Jiang; Hong-Xia Ma
Journal:  J Vet Med Sci       Date:  2017-09-02       Impact factor: 1.267

6.  Detection of β-Lactamase-Producing Enterococcus faecalis and Vancomycin-Resistant Enterococcus faecium Isolates in Human Invasive Infections in the Public Hospital of Tandil, Argentina.

Authors:  Celia M Schell; Ana P Tedim; Mercedes Rodríguez-Baños; Mónica D Sparo; Sabina Lissarrague; Juan A Basualdo; Teresa M Coque
Journal:  Pathogens       Date:  2020-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.